Phase I Study of Ficlatuzumab and Cetuximab in Cetuximab-Resistant, Recurrent/Metastatic Head and Neck CancerJulie E. Bauman, Laura P. Stabile, William E. Gooding et al.|Cancers|2020Cited by 30